Michele Marin Appointed as New Member of the Italian Board of Directors

Food and Healthcare Press Releases Thursday May 3, 2018 11:42
SAN DANIELE DEL FRIULI, Italy--3 May--PRNewswire/InfoQuest

LimaCorporate has appointed Mr. Michele Marin as a Member of the Italian Board of Directors as of 27th April 2018 in replacement of Daniele Negrato. This appointment follows the previous announcement regarding Michele Marin appointment as CFO of LimaCorporate as of 1st March 2018.

(Logo: https://mma.prnewswire.com/media/637371/Lima_Corporate_Logo.jpg )

After having earned a Business Degree from the Ca' Foscari University of Venice, Michele started his career at PriceWaterhouseCoopers in 1995 and worked in different multinational companies until becoming CFO for Salmoiraghi & Vigano, the Italy-based optical retailer, in 2013. Following the acquisition of the company by Luxottica, he assumed to the role of Chief Accounting Officer for Luxottica in April 2017.

In addition to the functions within the Board of Directors and those as LimaCorporate's group CFO, Michele is in charge of the Legal Affairs and Compliance and the IT departments.
About LimaCorporate

LimaCorporate is a global medical device company providing reconstructive orthopedic solutions to surgeons who face the challenges of improving the quality of life of their patients. Based in Italy, LimaCorporate is committed to the development of innovative products and procedures to enable surgeons to select ideal solution for every individual patient. LimaCorporate's product range includes large joint revision and primary implants and complete extremities solutions including fixation.

For additional information on the Company, please visit: http://www.limacorporate.com
Limacorporate S.p.A.
Via Nazionale, 52
33038 Villanova di San Daniele
Udine - Italy
T: +39-0432-945-511
E: info@limacorporate.com
Source: Limacorporate S.p.A.

Latest Press Release

Singapore#s first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer

Lion TCR Pte. Ltd., a Singapore-based Biotech company receives approval from Health Sciences Authority (HSA), Singapore, for its Phase I/II multicentre clinical study of its product candidate (LioCyx(TM)) for treatment of relapsed liver cancer post-liver...

Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

- Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research - Expands company's foundational CRISPR cutting and integration IP necessary to correct genetic defects in gene therapy patients - Merck to...

Kaneka officially starts continuous manufacturing under GMP

Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Mamoru Kadokura) have installed continuous manufacturing equipment to be applied to pharmaceutical products at Kaneka Singapore Co. (Pte.) Ltd, (Headquarters: Singapore; President: Kazuhiko...

TIENS Group opens new high-tech Experience Store in Shenzhen

TIENS Group, one of leading corporations in the Healthcare industry, unveiled a new high-tech Customer Experience Store in Shenzhen. Li Jinyuan, founder and chairman of TIENS group, announced the official opening of its first store in the world on August...

Sotera Health#s Nordion completes the sale of its medical isotopes business to BWXT

- Nordion's increased focus on gamma technologies supports Sotera Health's company-wide commitment to Safeguarding Global Health(TM) Sotera Health LLC, the world's leading, fully integrated protector of global health, today announced the closing of the...

Related Topics